Anuh Pharma Ltd vs Parmax Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Anuh Pharma Ltd is ₹ 85.43 as of 05 May 15:30 . The P/E Ratio of Anuh Pharma Ltd changed from 15.9 on March 2021 to 15.8 on March 2025 . This represents a CAGR of -0.13% over 5 yearsThe P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Anuh Pharma Ltd changed from ₹ 452.51 crore on March 2021 to ₹ 745.92 crore on March 2025 . This represents a CAGR of 10.51% over 5 yearsThe Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 years The revenue of Anuh Pharma Ltd for the Dec '25 is ₹ 201.29 crore as compare to the Sep '25 revenue of ₹ 186.86 crore. This represent the growth of 7.72% The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 4.33 crore as compare to the Sep '25 revenue of ₹ 2.54 crore. This represent the growth of 70.47% The ebitda of Anuh Pharma Ltd for the Dec '25 is ₹ 20.91 crore as compare to the Sep '25 ebitda of ₹ 12.86 crore. This represent the growth of 62.6% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ -0.19 crore as compare to the Sep '25 ebitda of ₹ -1.58 crore. This represent the decline of -87.97% The net profit of Anuh Pharma Ltd changed from ₹ 9.51 crore to ₹ 13.45 crore over 7 quarters. This represents a CAGR of 21.91% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.73 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Anuh Pharma Ltd changed from 26.43 % on March 2021 to 15.88 % on March 2025 . This represents a CAGR of -9.69% over 5 yearsThe Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anuh Pharma Ltd

Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs).
The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals.
The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals.
It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra. The Company was incorporated on February 19, 1960.
The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra.

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

FAQs for the comparison of Anuh Pharma Ltd and Parmax Pharma Ltd

Which company has a larger market capitalization, Anuh Pharma Ltd or Parmax Pharma Ltd?

Market cap of Anuh Pharma Ltd is 798 Cr while Market cap of Parmax Pharma Ltd is 12 Cr

What are the key factors driving the stock performance of Anuh Pharma Ltd and Parmax Pharma Ltd?

The stock performance of Anuh Pharma Ltd and Parmax Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anuh Pharma Ltd and Parmax Pharma Ltd?

As of May 5, 2026, the Anuh Pharma Ltd stock price is INR ₹79.7. On the other hand, Parmax Pharma Ltd stock price is INR ₹32.5.

How do dividend payouts of Anuh Pharma Ltd and Parmax Pharma Ltd compare?

To compare the dividend payouts of Anuh Pharma Ltd and Parmax Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.